ADMA Biologics, Inc. (ADMA) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
ADMA Biologics, Inc. (ADMA) Bundle
Looking to assess the intrinsic value of ADMA Biologics, Inc.? Our (ADMA) DCF Calculator integrates real-world data with comprehensive customization features, enabling you to refine your forecasts and make more informed investment choices.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.3 | 42.2 | 80.9 | 154.1 | 258.2 | 447.7 | 776.2 | 1,345.8 | 2,333.2 | 4,045.3 |
| Revenue Growth, % | 0 | 43.85 | 91.72 | 90.36 | 67.59 | 73.38 | 73.38 | 73.38 | 73.38 | 73.38 |
| EBITDA | -36.0 | -59.8 | -53.3 | -39.7 | 5.1 | -259.4 | -449.7 | -779.7 | -1,351.8 | -2,343.8 |
| EBITDA, % | -122.76 | -141.69 | -65.89 | -25.78 | 1.98 | -57.94 | -57.94 | -57.94 | -57.94 | -57.94 |
| Depreciation | 3.3 | 3.9 | 5.5 | 7.1 | 8.3 | 31.4 | 54.4 | 94.4 | 163.7 | 283.8 |
| Depreciation, % | 11.1 | 9.34 | 6.79 | 4.62 | 3.23 | 7.01 | 7.01 | 7.01 | 7.01 | 7.01 |
| EBIT | -39.3 | -63.8 | -58.8 | -46.8 | -3.2 | -272.5 | -472.4 | -819.1 | -1,420.1 | -2,462.2 |
| EBIT, % | -133.86 | -151.03 | -72.68 | -30.4 | -1.24 | -60.86 | -60.86 | -60.86 | -60.86 | -60.86 |
| Total Cash | 26.8 | 55.9 | 51.1 | 86.5 | 51.4 | 295.8 | 512.8 | 889.0 | 1,541.4 | 2,672.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3.5 | 13.2 | 28.6 | 15.5 | 27.4 | 88.8 | 153.9 | 266.9 | 462.7 | 802.3 |
| Account Receivables, % | 11.82 | 31.35 | 35.31 | 10.06 | 10.62 | 19.83 | 19.83 | 19.83 | 19.83 | 19.83 |
| Inventories | 53.1 | 81.5 | 124.7 | 163.3 | 172.9 | 418.1 | 724.9 | 1,256.8 | 2,179.1 | 3,778.0 |
| Inventories, % | 180.81 | 193.12 | 154.09 | 105.97 | 66.96 | 93.39 | 93.39 | 93.39 | 93.39 | 93.39 |
| Accounts Payable | 9.2 | 11.1 | 12.4 | 13.2 | 15.7 | 78.3 | 135.8 | 235.5 | 408.3 | 707.9 |
| Accounts Payable, % | 31.26 | 26.23 | 15.36 | 8.59 | 6.06 | 17.5 | 17.5 | 17.5 | 17.5 | 17.5 |
| Capital Expenditure | -3.8 | -12.7 | -13.5 | -13.9 | -5.0 | -63.4 | -109.9 | -190.5 | -330.3 | -572.7 |
| Capital Expenditure, % | -12.99 | -30.14 | -16.69 | -9.03 | -1.93 | -14.16 | -14.16 | -14.16 | -14.16 | -14.16 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -46.4 | -73.7 | -69.3 | -60.5 | -3.2 | -272.5 | -472.4 | -819.1 | -1,420.1 | -2,462.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -94.3 | -118.9 | -134.5 | -92.0 | -19.0 | -548.3 | -842.3 | -1,460.4 | -2,532.0 | -4,390.0 |
| WACC, % | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -7,276.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -4,478 | |||||||||
| Terminal Value | -76,535 | |||||||||
| Present Terminal Value | -52,450 | |||||||||
| Enterprise Value | -59,727 | |||||||||
| Net Debt | 90 | |||||||||
| Equity Value | -59,817 | |||||||||
| Diluted Shares Outstanding, MM | 224 | |||||||||
| Equity Value Per Share | -267.07 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real ADMA financials.
- Real-World Data: Historical data and forward-looking estimates (highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on ADMA’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and usability, complete with step-by-step instructions.
Key Features
- Customizable Financial Inputs: Adjust essential parameters such as revenue projections, gross margin %, and operational costs.
- Instant DCF Analysis: Quickly computes intrinsic value, net present value (NPV), and other key metrics.
- High-Precision Valuation: Leverages ADMA Biologics’ actual financial data for accurate valuation results.
- Effortless Scenario Testing: Explore various assumptions and analyze results with ease.
- Efficiency Booster: Streamline the valuation process without the hassle of developing intricate models from the ground up.
How It Works
- Download the Template: Gain immediate access to the Excel-based ADMA DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates ADMA’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for ADMA Biologics, Inc. (ADMA)?
- Accurate Data: Real ADMA financials provide trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations mean you won’t have to start from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Easy-to-navigate layout and clear instructions ensure accessibility for all users.
Who Should Use This Product?
- Investors: Accurately assess ADMA Biologics, Inc.'s (ADMA) fair value prior to making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to ADMA.
- Consultants: Efficiently customize the template for valuation reports tailored to ADMA's clients.
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech companies.
- Educators: Implement it as a teaching resource to illustrate valuation methodologies relevant to the biotech sector.
What the Template Contains
- Historical Data: Contains ADMA Biologics, Inc.'s (ADMA) previous financials and foundational forecasts.
- DCF and Levered DCF Models: Comprehensive templates for calculating the intrinsic value of ADMA Biologics, Inc. (ADMA).
- WACC Sheet: Pre-configured calculations for the Weighted Average Cost of Capital.
- Editable Inputs: Adjust critical drivers such as growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A thorough breakdown of ADMA Biologics, Inc.'s (ADMA) financials.
- Interactive Dashboard: Dynamically visualize valuation results and forecasts.